Author
Listed:
- Nicolas Gonzalo Núñez
(PSL Research University, INSERM U932
University of Zurich, Winterthurerstr. 190)
- Jimena Tosello Boari
(PSL Research University, INSERM U932)
- Rodrigo Nalio Ramos
(PSL Research University, INSERM U932)
- Wilfrid Richer
(PSL Research University, INSERM U932)
- Nicolas Cagnard
(Paris-Descartes Bioinformatics Platform)
- Cyrill Dimitri Anderfuhren
(University of Zurich, Winterthurerstr. 190)
- Leticia Laura Niborski
(PSL Research University, INSERM U932)
- Jeremy Bigot
(PSL Research University, INSERM U932)
- Didier Meseure
(PSL Research University, Departement de Biologie des Tumeurs
Centre d’Investigation Clinique Biotherapie CICBT 1428, Institut Curie)
- Philippe Rochere
(PSL Research University, INSERM U932)
- Maud Milder
(PSL Research University, Departement de Biologie des Tumeurs
Centre d’Investigation Clinique Biotherapie CICBT 1428, Institut Curie)
- Sophie Viel
(PSL Research University, INSERM U932)
- Delphine Loirat
(PSL Research University, INSERM U932
Centre d’Investigation Clinique Biotherapie CICBT 1428, Institut Curie
PSL Research University, Departement d’Oncologie Medicale)
- Louis Pérol
(PSL Research University, INSERM U932)
- Anne Vincent-Salomon
(PSL Research University, Departement de Biologie des Tumeurs
Centre d’Investigation Clinique Biotherapie CICBT 1428, Institut Curie)
- Xavier Sastre-Garau
(PSL Research University, Departement de Biologie des Tumeurs
6, avenue de Bourgogne CS 30519)
- Becher Burkhard
(University of Zurich, Winterthurerstr. 190)
- Christine Sedlik
(PSL Research University, INSERM U932
Centre d’Investigation Clinique Biotherapie CICBT 1428, Institut Curie)
- Olivier Lantz
(PSL Research University, INSERM U932
PSL Research University, Departement de Biologie des Tumeurs
Centre d’Investigation Clinique Biotherapie CICBT 1428, Institut Curie)
- Sebastian Amigorena
(PSL Research University, INSERM U932
Centre d’Investigation Clinique Biotherapie CICBT 1428, Institut Curie)
- Eliane Piaggio
(PSL Research University, INSERM U932
Centre d’Investigation Clinique Biotherapie CICBT 1428, Institut Curie)
Abstract
Tumor-draining lymph node (TDLN) invasion by metastatic cells in breast cancer correlates with poor prognosis and is associated with local immunosuppression, which can be partly mediated by regulatory T cells (Tregs). Here, we study Tregs from matched tumor-invaded and non-invaded TDLNs, and breast tumors. We observe that Treg frequencies increase with nodal invasion, and that Tregs express higher levels of co-inhibitory/stimulatory receptors than effector cells. Also, while Tregs show conserved suppressive function in TDLN and tumor, conventional T cells (Tconvs) in TDLNs proliferate and produce Th1-inflammatory cytokines, but are dysfunctional in the tumor. We describe a common transcriptomic signature shared by Tregs from tumors and nodes, including CD80, which is significantly associated with poor patient survival. TCR RNA-sequencing analysis indicates trafficking between TDLNs and tumors and ongoing Tconv/Treg conversion. Overall, TDLN Tregs are functional and express a distinct pattern of druggable co-receptors, highlighting their potential as targets for cancer immunotherapy.
Suggested Citation
Nicolas Gonzalo Núñez & Jimena Tosello Boari & Rodrigo Nalio Ramos & Wilfrid Richer & Nicolas Cagnard & Cyrill Dimitri Anderfuhren & Leticia Laura Niborski & Jeremy Bigot & Didier Meseure & Philippe R, 2020.
"Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients,"
Nature Communications, Nature, vol. 11(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17046-2
DOI: 10.1038/s41467-020-17046-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17046-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.